In the Austrian Breast and Colorectal Cancer Study Group–12 (ABCSG-12) trial, an unfavorable trend was found for the use of anastrozole as compared to tamoxifen in combination with ovarian function suppression with respect to overall survival [ 27 ].
← all excerpts
The correlation of age with chemotherapy-induced ovarian function failure in breast cancer patients.
1
—
—